Russia agrees to produce coronavirus vaccine Sputnik V in India

Russia’s sovereign wealth fund and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses of the Sputnik V vaccine against COVID-19 per year in India, according to a statement on the Sputnik V Twitter account on November 27. (Read More)


Be the first to comment

Leave a Reply

Your email address will not be published.